1. Articles in category: Other Business News

    1-24 of 926 1 2 3 4 ... 37 38 39 »
    1. Swept-Source OCT: Patent License Agreement between Massachusetts General Hospital and Heidelberg Engineering

      Swept-Source OCT: Patent License Agreement between Massachusetts General Hospital and Heidelberg Engineering

      Heidelberg Engineering has entered into a patent license agreement with Massachusetts General Hospital (MGH) in Boston. The agreement grants global and exclusive rights to 77 basic patents and patent applications which relate to swept-source OCT technology and its application in ophthalmology. Spectral domain OCT has become indispensable to eye care professionals worldwide to diagnose and follow-up patients with diseases of the posterior segment of the eye, such as age-related macular degeneration, diabetic retinopathy, or glaucoma. Swept-source OCT technology has specific characteristics which are ideal to acquire comprehensive information about a wide variety of properties of the anterior part of the ...

      Read Full Article
    2. Optovue announces 300 AngioVue systems installed outside the US

      Optovue announces 300 AngioVue systems installed outside the US

      Haag-Streit UK (HS-UK), UK distributor of the Optovue OCT product portfolio, is pleased to announce that Optovue recently installed its 300th AngioVue OCT-A system outside of the United States. After a successful introduction of the revolutionary AngioVue imaging system at the ESCRS meeting in London in September 2014, Universities, hospitals and private clinics are eagerly adopting the technology. Many of the sales include recent installations into UK hospitals. The AngioVue imaging system is a non-invasive, dyeless technique for visualising the presence of ocular flow in the vessels. AngioVue allows clinicians to assess microvasculature and perfusion in ocular diseases with unprecedented ...

      Read Full Article
    3. Rowe Technical Design, Inc. announces that Whole Model Eye for OCT (Tissue Phantom) is now in production!

      Rowe Technical Design, Inc. announces that Whole Model Eye for OCT (Tissue Phantom) is now in production!

      Rowe Technical Design, Inc. (RTD), developers of the 1st commercial optical tissue phantom for OCT, announces that their latest version of the Whole Model Eye complete with Cornea, Crystalline Lens and Retina tissue phantoms for OCT has now been released for full serial production. “We’re excited because this is our third serial production model eye, following up on the very successful anterior chamber and OCT model eyes with retina tissue phantom” notes T. Scott Rowe, company founder and president. “We are extremely pleased with the customer feedback so far, and we are ready for serial production. This is the ...

      Read Full Article
      Mentions: T. Scott Rowe
    4. Acquisition of Spin-out Company Bioptigen to Bring Duke Imaging Technology to New Markets

      Acquisition of Spin-out Company Bioptigen to Bring Duke Imaging Technology to New Markets

      In June 2015, microscopy and imaging systems company Leica Microsystems acquired Bioptigen Inc., a company born from Duke's Pratt School of Engineering. Formed in 2004, Bioptigen has become a leader in optical coherence tomography (OCT), an imaging technique that uses light to capture extremely high-resolution, three-dimensional pictures of the eye. Bioptigen was the brainchild of Duke’s Michael J. Fitzpatrick Professor of Engineering Joseph Izatt and CEO Eric Buckland. Since its launch, the company secured more than 60 issued patents in OCT technology, many of which were licensed from intellectual property developed by Izatt, his students, and collaborators at ...

      Read Full Article
    5. Perimeter Medical Imaging Closes Oversubscribed $5 Million Series A Financing Round Led By Roadmap Capital

      Perimeter Medical Imaging Closes Oversubscribed $5 Million Series A Financing Round Led By Roadmap Capital

      Perimeter Medical Imaging, Inc., a developer of real time imaging systems for in-surgery tissue assessment, is pleased to announce the closing of their $5 million Series A financing. The round was led by Roadmap Capital with participation from EPIC Capital, NorthView Ventures and Pathfinder Asset Management. Funds will support the completion of their current clinical study at Princess Margaret Cancer Centre as well as product development and FDA regulatory clearance for their first tissue imaging product. Perimeter’s ground-breaking new Optical Tissue Imaging System (OTIS™) is an intraoperative medical imaging tool that provides clinicians with the ability to visualize the ...

      Read Full Article
    6. FedDev Ontario Supports Commercialization of Perimeter Medical Imaging’s OTIS™ Surgical Tissue Imaging System

      FedDev Ontario Supports Commercialization of Perimeter Medical Imaging’s OTIS™ Surgical Tissue Imaging System

      Perimeter Medical Imaging, Inc., a developer of real time imaging systems for in-surgery tumour margin assessment, today announced it is receiving up to $980,000 from the Government of Canada through the Federal Economic Development Agency for Southern Ontario (FedDev Ontario). The announcement was made at Perimeter’s new location in Toronto by John Carmichael, Member of Parliament for Don Valley West, on behalf of the Honourable Gary Goodyear, Minister of State for the Federal Economic Development Agency for Southern Ontario (FedDev Ontario). This investment will support the next phase of product and clinical development as well as accelerate regulatory ...

      Read Full Article
    7. Optovue Introduces AngioVue OCTA in Glaucoma

      Optovue Introduces AngioVue OCTA in Glaucoma

      Optovue, a pioneer in optical coherence tomography angiography (OCTA) and leader in commercialization of the technology, announced that it has expanded the application of its OCT Angiography technology into glaucoma. After a successful introduction of the revolutionary AngioVue Imaging System to retina last year, Optovue has worked to develop clinical applications in glaucoma as well.

      The use of the AngioVue Imaging System in glaucoma was introduced at a highly successful symposium at the 6th World Glaucoma Congress in Hong Kong. The Optovue-hosted event featured presentations on the clinical applications of OCTA in glaucoma research using the company's AngioVue OCTA ...

      Read Full Article
    8. Transformative clinical results with VivoSight in the diagnosis of Basal Cell Carcinoma: Data to be presented at the World Congress of Dermatology in Vancouver

      Transformative clinical results with VivoSight in the diagnosis of Basal Cell Carcinoma: Data to be presented at the World Congress of Dermatology in Vancouver

      Michelson Diagnostics, a medical device company focused on multi-beam Optical Coherence Tomography (‘OCT’) technology, today announces that data showing significant improvement in the diagnosis of basal-cell carcinoma (BCC) using its VivoSight multibeam OCT scanner will be presented at the World Congress of Dermatology (Vancouver, June 8-13). In addition to being an efficient, non-invasive way to diagnose BCC and other non-melanoma skin cancers, using the VivoSight OCT scanner has the potential to reduce biopsies and surgery, thereby reducing scarring for patients. Joint lead investigator, Dr Martina Ulrich, CMB Collegium, Berlin, Germany, will outline the results of this independent multi-centre, prospective clinical ...

      Read Full Article
    9. ZEISS Presents Its New Generation of Vascular Imaging: OCT Angiography

      ZEISS Presents Its New Generation of Vascular Imaging: OCT Angiography

      Nearly two decades ago, ZEISS was the first company to introduce optical coherence tomography (OCT) for clinical use in ophthalmology and optometry. The 20 presentations on OCT angiography by ZEISS and its research collaborators at this year’s ARVO meeting in May are testament to the company’s dedication to continued innovation and advancing the practice of medicine. ZEISS is developing OCT angiography for both spectral domain (SD) and swept source platforms. The OCT angiography application on the SD platform is currently under FDA review and is 510(k) pending. “The en face angiograms from the ZEISS SD-OCT angiography prototype ...

      Read Full Article
    10. Cataract Surgery and the LenSx® Femtosecond Laser System—2015 Update

      Cataract Surgery and the LenSx® Femtosecond Laser System—2015 Update

      Femtosecond laser-assisted cataract surgery continues to gain popularity as clinicians adopt the technology with the desire to improve the safety and efficacy of cataract surgery. The technology continues to evolve as clinical experience points to improvements to better meet the needs of surgeons and patients. The effect of these system updates, and the increasing body of experience with femtosecond laser systems, has reduced complication rates and seen the technology applied to more challenging cases. This article provides an updated review of the LenSx® femtosecond Laser system, including recent system modifications and the most- recent published literature. The LenSx® Laser system ...

      Read Full Article
      Mentions: LenSx
    11. Leica Microsystems to Acquire OCT Company Bioptigen

      Leica Microsystems to Acquire OCT Company Bioptigen

      Integration of Optical Coherence Tomography (OCT) Opens up New Avenues for Ophthalmology and Life Science Research Leica Microsystems, a global leader in microscopy and imaging systems, has signed a definitive agreement to acquire Bioptigen, Inc. to strengthen its position in the ophthalmology market. Bioptigen is a technology leader in the field of optical coherence tomography (OCT). The integration of OCT imaging into Leica Microsystems’ surgical microscopes will assist ophthalmologists during eye surgery. Bioptigen develops and manufactures innovative OCT systems and software and is globally successful with products for clinical as well as translational research applications. Using low-power, near-infrared light, Bioptigen ...

      Read Full Article
    12. New Data Further Emphasize the Clinical Benefits of St. Jude Medical’s OCT Technology

      New Data Further Emphasize the Clinical Benefits of St. Jude Medical’s OCT Technology

      St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced preliminary results from the ILUMIEN I trial and final results from the ILUMIEN II clinical study. Taken together, the findings from both studies show that with resolution up to 10 times higher than intravascular ultrasound (IVUS), optical coherence tomography (OCT) imaging can help improve stent selection and deployment, better support clinical decision-making and improve patient outcomes. Data from both studies were presented today as late-breaking clinical trials at EuroPCR 2015, and further advance the use of OCT imaging alongside percutaneous coronary intervention (PCI). During PCI procedures, physicians ...

      Read Full Article
    13. Cambridge role in new medical device

      Cambridge role in new medical device

      VivoSight Dx is aimed at dermatologists seeking an imaging system that will enhance their ability to make rapid and accurate diagnostic decisions for their patients. Michelson Diagnostics approached eg technology to undertake the aesthetic and detailed design of the product trolley and enclosure and the assembly methodology of the functional elements of the OCT system. eg and Michelson worked with dermatologists who were already using the first generation OCT system in order to gain insight into how the machine was used and how the system could be developed to enhance the experience of both the user and the patient. From ...

      Read Full Article
    14. Avinger Announces 30-Day VISION Trial Results at EuroPCR 2015

      Avinger Announces 30-Day VISION Trial Results at EuroPCR 2015

      Avinger, Inc., (Nasdaq: AVGR ) a developer and manufacturer of image-guided, catheter-based systems for the treatment of peripheral arterial disease (PAD) and pioneer of the lumivascular approach to treating vascular disease, today announced 30-day interim results for its VISION clinical study. VISION is designed to evaluate the safety and efficacy of the Pantheris™ system to perform directional atherectomy, while for the first time ever allowing physicians to use real-time intravascular imaging to aid in the removal of plaque from diseased lower extremity arteries. Results were presented by Arne Schwindt, M.D. of St. Franziskus Hospital in Muenster, Germany at the EuroPCR ...

      Read Full Article
    15. Micro-Tech Developing a SS-OCT Endoscopic System for Gastroenterology

      Micro-Tech Developing a SS-OCT Endoscopic System for Gastroenterology

      Micro-Tech an medical company in China established in 1999 is developing a SS-OCT endoscopic system. The system was shown at DDW 2015 and was developed by Jiefeng Xi a Principle Engineer at Micro-Tech and former PhD student at Johns Hopkins who graduated in July 2014. For more information click HERE .

      Read Full Article
    16. New Journal Article Highlights Mechanical Effects of Orbital Atherectomy and Rotational Atherectomy in Treating Heavily Calcified Coronary Lesions

      New Journal Article Highlights Mechanical Effects of Orbital Atherectomy and Rotational Atherectomy in Treating Heavily Calcified Coronary Lesions

      Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) today announced that a new article e-published in May 2015 in The Journal of Catheterization and Cardiovascular Intervention highlights the mechanical effect of orbital atherectomy (OA) and rotational atherectomy (RA) in treating heavily calcified coronary lesions. ” The article, titled “Optical Coherence Tomography Assessment of the Mechanistic Effects of Rotational and Orbital Atherectomy in Severely Calcified Coronary Lesions,” details results from a study led by Dr. Annapoorna Kini, Professor of Cardiology at the Mount Sinai Hospital and Icahn School of Medicine, and Director of The Cardiac Catheterization Lab at Mount Sinai Hospital. Said study co-investigator ...

      Read Full Article
    17. New Clinical Data Using the NvisionVLE® Imaging System to be Presented at Digestive Disease Week® 2015

      New Clinical Data Using the NvisionVLE® Imaging System to be Presented at Digestive Disease Week® 2015

      NinePoint Medical, Inc. , an emerging leader in the development of medical devices for advanced imaging, today announced that new clinical data relating to its proprietary NvisionVLE ® Imaging System, will be presented in a series of oral and poster presentations during Digestive Disease Week ® (DDW ® ) 2015. The annual meeting will take place May 16-19th in Washington, DC. The schedule for scientific presentations related to advanced optical coherence tomography (OCT) and the NvisionVLE ® Imaging System at DDW 2015 is provided below. SATURDAY, May 16, 2015 Three posters will be presented on Saturday, May 16 at 9:30am in Hall C of Walter ...

      Read Full Article
    18. NIDEK launches MP-3 Microperimeter

      NIDEK launches MP-3 Microperimeter

      NIDEK CO., LTD., a global leader in the design, manufacture, and distribution of ophthalmic, optometric, and lens edging equipment, is pleased to announce the launch of the MP-3 Microperimeter. Assessment of retinal morphology has advanced significantly due to the introduction of Optical Coherence Tomography into clinical practice. Advances in the functional evaluation of retinal pathology are due to the use of the microperimeter. The MP-3 measures local retinal sensitivity for functional assessment of the retina. The results can be displayed over a color fundus image, correlating retinal anatomy to retinal function. For enhanced clinical assessment, the MP-3 now includes a ...

      Read Full Article
      Mentions: Nidek
    19. GSI outlines post-JK strategy

      GSI outlines post-JK strategy

      US-based GSI Group says that its wide-ranging efforts to realign the business around laser, medical and precision motion technologies is now largely complete – following the sale of its fiber laser division JK Lasers to Trumpf subsidiary SPI Lasers last month . CEO John Roush told an investor conference call to discuss the Massachusetts firm’s latest financial results: “In the end, the high-power fiber laser materials processing application of JK did not have synergy with our other product lines, sales channels or infrastructure. So selling the business and redeployment the capital into our core businesses was definitely the right move for ...

      Read Full Article
    20. Michelson Diagnostics launches next generation OCT System – VivoSight Dx

      Michelson Diagnostics launches next generation OCT System – VivoSight Dx

      Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography (‘OCT’) technology, today announces the launch of VivoSight Dx, the Company’s second generation OCT system, at the German Society of Dermatology 48 th Congress 2015 (DDG 2015), 29 th April – 2 nd May 2015, Berlin. VivoSight Dx is aimed at dermatologists seeking an imaging system that will enhance their ability to make rapid, accurate diagnostic decisions for their patients. It is lighter, more compact and more mobile than the first generation OCT system, enabling its use in a consulting room at short notice. VivoSight Dx ...

      Read Full Article
    21. Haag-Streit UK launch the Optovue AngioVue in the UK

      Haag-Streit UK launch the Optovue AngioVue in the UK

      Haag-Streit UK (HS-UK), the leading manufacturer and distributor of gold-standard optometry and ophthalmic equipment, is pleased to announce the launch of the AngioVue OCT Angiography (OCTA) system, in the UK. The AngioVue is the first commercial OCTA system capable of imaging and displaying the function of the ocular microvasculature, through a non-invasive procedure. The innovative system uses a unique dyeless technique to quickly evaluate the functional blood flow of the retina and optic nerve. This method allows the procedure to be performed in everyday clinical practice and unlike fluorescein angiography, can be repeated as often as required, and with no ...

      Read Full Article
      Mentions: Optovue Haag-Streit
    22. Heidelberg Engineering Announces 85,000 Hz OCT2; Next Generation SPECTRALIS OCT Module

      Heidelberg Engineering Announces 85,000 Hz OCT2; Next Generation SPECTRALIS OCT Module

      Heidelberg Engineering announces significant improvements to the SPECTRALIS ® OCT2 Module. The OCT2 Module brings the next generation OCT technology to the SPECTRALIS diagnostic imaging platform. It combines a high scan rate with Heidelberg Engineering’s proprietary TruTrack Active Eye Tracking, to provide unmatched image quality and significantly improved acquisition speed. New applications such as OCT Angiography* will build on the OCT2 Module. Since its debut at the 2014 American Academy of Ophthalmology in Chicago, the OCT2 Module is an option for all new SPECTRALIS models. In addition, a large number of SPECTRALIS devices in use, depending on their technical specifications ...

      Read Full Article
    23. HAAG-STREIT SURGICAL: iOCT® camera receives 510(k) clearance

      HAAG-STREIT SURGICAL: iOCT® camera receives 510(k) clearance

      HAAG-STREIT SURGICAL announced its intraoperative-OCT camera has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for marketing on the largest medical device market in the world. The intraoperative Optical Coherence Tomography (iOCT®) is already being successfully used for cataract operations, lamellar keratoplasties, membrane peelings, and for the treatment of retinal disorders. The ASCRS congress, to be held in San Diego (18 – 21 April 2015), marks the launch of the iOCT® system in the US. During the course of the surgical procedure, the iOCT® system allows non-invasive, contact-free imaging so that the structures and layers within ...

      Read Full Article
    24. Michelson Diagnostics Appoints Peter Senger as Country Manager Germany

      Michelson Diagnostics Appoints Peter Senger as  Country Manager Germany

      Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography (‘OCT’) technology, today announces the appointment of Peter Senger as Country Manager Germany, with immediate effect. Peter, aged 46, has more than 25 years’ experience in sales and marketing and over 15 years of commercial experience in the medical device industry in Germany, with a track record of building early stage businesses with new and disruptive technologies. Most recently, Peter was Regional Business Manager at AngioDynamics, where he was instrumental in the introduction of the NanoKnife ® System into Germany and helped to secure reimbursement for the ...

      Read Full Article
    1-24 of 926 1 2 3 4 ... 37 38 39 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Popular Articles

  3. Organizations in the News

    1. (1 articles) Harvard University
    2. (1 articles) Massachusetts General Hospital
  4. People in the News

    1. (1 articles) Bruno Lumbroso
    2. (1 articles) Brett E. Bouma
    3. (1 articles) T. Scott Rowe
  5. OCT Companies in the News

    1. (1 articles) Optovue
    2. (1 articles) Haag-Streit
    3. (1 articles) Heidelberg Engineering